DIANTHUS THERAPEUTICS INC
DNTHNASDAQ🏆 #1354 by market capEarnings Nov 3US Equity
$87.16▼ $0.66 (−0.76%)
🌙 After hours$87.16▲ 0.00%Regular close · extended-hours price shownTrack DNTH
Get earnings, price moves & breaking news on Telegram
24h▼ 0.8%
7d▼ 11.3%
14d▼ 16.8%
30d▼ 17.6%
ytd▲ 111.5%
1y▲ 120.3%
🏦Market Cap
$4.88B
Small Cap
📈Revenue Growth (YoY)
-67.3%
Declining
📊Gross Margin
96.0%
High
💵FCF Margin
-8178.0%
Thin
⚖️P/S Ratio
2505.9x
Expensive
Otter Score
60
Fair
DIANTHUS THERAPEUTICS INC
DNTHAnalyst Ratings
Price
$87.16
Total
11
Raised
1
Lowered
0
Avg PT
$126.83
H / L
$158 / $98
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-08-06 | — | — |
Truist Securities | Reiterated | Buy | 2026-08-06 | — | — |
Wedbush | Reiterated | Outperform | 2026-08-05 | $122.00 | +40.00% |
Evercore ISI Group | Reiterated | Outperform | 2026-08-03 | — | — |
Baird | Reiterated | Outperform | 2026-03-10 | — | — |
Clear Street | Reiterated | Buy | 2026-03-10 | — | — |
Raymond James | Upgraded | Outperform → Strong Buy | 2026-03-10 | $131.00 | +50.30% |
Oppenheimer | Reiterated | Outperform | 2026-03-09 | $145.00 | +66.40% |
Guggenheim | Reiterated | Buy | 2026-03-04 | $100.00 | +14.70% |
Jefferies | Reiterated | Buy | 2026-02-02 | $132.00 | +51.40% |
Stifel | Reiterated | Buy | 2025-09-12 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-08-06
—
—
Truist Securities
Reiterated · Buy · 2026-08-06
—
—
Wedbush
Reiterated · Outperform · 2026-08-05
$122.00
+40.00%
Evercore ISI Group
Reiterated · Outperform · 2026-08-03
—
—
Baird
Reiterated · Outperform · 2026-03-10
—
—
Clear Street
Reiterated · Buy · 2026-03-10
—
—
Raymond James
Upgraded · Outperform → Strong Buy · 2026-03-10
$131.00
+50.30%
Oppenheimer
Reiterated · Outperform · 2026-03-09
$145.00
+66.40%
Guggenheim
Reiterated · Buy · 2026-03-04
$100.00
+14.70%
Jefferies
Reiterated · Buy · 2026-02-02
$132.00
+51.40%
Stifel
Reiterated · Buy · 2025-09-12
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space